Mobile Underwriting Health Assessment in 2027: What Product Managers Should Plan For

The mobile underwriting health assessment space has moved faster in the last two years than it did in the previous decade. Carriers that launched accelerated underwriting pilots in 2023 are now running production programs. Others are still debating vendor selection. If you're a product manager at a life insurance carrier or insurtech, 2027 is the year where the gap between leaders and laggards becomes permanent. The decisions you make on your product roadmap over the next twelve months will determine which side of that line your organization falls on.

Munich Re's 2024 Accelerated Underwriting Survey found that 85% of participating carriers now offer some form of accelerated underwriting, up from around 60% in 2019. But acceleration rates (the percentage of applicants who actually qualify for the fast track) remain stubbornly low at many carriers, often below 50%.

Where mobile health assessment stands right now

Most mobile underwriting health assessments in production today follow a similar pattern. The applicant downloads an app or opens a web link, answers some health questions, and maybe grants access to electronic health records or prescription history through vendors like MIB, Milliman IntelliScript, or ExamOne. The "mobile" part is mostly about the application interface, not the health data collection itself.

That's changing. Camera-based health screening using remote photoplethysmography (rPPG) can now extract heart rate, respiratory rate, heart rate variability, and blood pressure estimates from a smartphone camera in under 60 seconds. A comprehensive review published in Frontiers in Digital Health in 2025 by researchers at IntelliProve found that 81.4% of the published rPPG research bibliography dates from 2015 to 2025, with the field accelerating rapidly in the last three years. The technology is moving from lab validation to production deployment.

For product managers, the question isn't whether mobile health assessment will include real biometric capture. It's how soon your competitors will ship it.

What's actually different about the 2027 roadmap

The 2027 product roadmap for mobile underwriting health assessment looks different from the 2025 version in three concrete ways. Each one has specific implications for what product managers need to be building now.

Real-time biometrics replace self-reported data

John Hancock and Munich Re announced in September 2025 that they're collaborating on Munich Re's alitheia platform to drive higher instant underwriting decision rates. The direction is clear: carriers want to replace applicant questionnaires with actual measurement wherever possible. Self-reported health data has known reliability problems. Applicants forget medications, underestimate their weight, and round down their alcohol consumption.

Mobile health assessment in 2027 will capture biometric signals directly. Heart rate and blood pressure readings from a phone camera, combined with EHR pulls and Rx data, give underwriting engines something much closer to what a paramedical exam produces, but without sending a nurse to someone's house.

Continuous data replaces point-in-time snapshots

The insurance industry has historically assessed health at a single moment: the application date. RGA's research on accelerated underwriting points out that the protective value of health data depends heavily on its recency. A blood pressure reading from three years ago tells an underwriter almost nothing useful.

By 2027, product managers should plan for assessment models that can capture data at multiple points. An initial screen at application, a follow-up at policy delivery, and periodic check-ins during the policy term. This doesn't mean constant monitoring (that raises privacy issues carriers aren't ready for), but it does mean the technology stack needs to support re-assessment.

The underwriting engine becomes the integration bottleneck

Munich Re's work with MIB on electronic health records, combined with the growth of mobile biometric capture, means the amount of health data available to underwriters is about to spike. The bottleneck shifts from "we don't have enough data" to "our rules engine can't consume this data fast enough."

Product managers building for 2027 need to think about the data pipeline as much as the data source. (We covered the integration architecture in detail in our piece on how health screening integrates with underwriting engines.)

Mobile health assessment methods compared

Assessment method	Data captured	Applicant time	Requires equipment	Carrier cost per assessment	2027 readiness
Traditional paramedical exam	Blood, urine, BP, pulse, height/weight	30-45 min + scheduling	Yes (nurse visit, lab)	$100-200	Legacy
Telehealth interview	Self-reported health history	15-20 min	Phone/computer	$30-50	Mature
EHR + Rx data pull	Medical records, prescriptions	0 min (automated)	Applicant consent	$15-30	Mature
Phone-based rPPG scan	HR, HRV, RR, BP estimate	30-60 seconds	Smartphone camera	$2-10	Emerging
Wearable device data	Continuous HR, activity, sleep	Ongoing	Smartwatch/band	Variable	Early
Combined digital (EHR + rPPG + Rx)	Full biometric + medical history	Under 2 min	Smartphone	$20-40	Building

The combined digital approach is where the 2027 roadmap points. Product managers who can integrate EHR pulls, prescription data, and camera-based biometric capture into a single mobile flow will have a meaningful advantage in both conversion rates and underwriting accuracy.

What product managers should build now

Planning for 2027 means starting specific workstreams in 2026. Here's what should be on the roadmap, in rough priority order.

Vendor evaluation for camera-based biometrics

The rPPG vendor landscape is maturing but still fragmented. Companies like Circadify are building camera-based vital sign capture specifically for insurance and healthcare use cases. Product managers should be running proof-of-concept evaluations now, not in 2027 when the pressure hits. Key evaluation criteria: SDK integration complexity, supported vital signs, device compatibility range, and data output format (does it match what your underwriting engine expects?).

Data normalization layer

Raw biometric data from a phone camera scan isn't immediately useful to an underwriting rules engine. You need a normalization layer that converts readings into risk-relevant inputs. What does a heart rate of 78 bpm mean for a 45-year-old female with controlled hypertension? That translation layer is engineering work that takes months to build and validate. Start it now.

Applicant experience optimization

Deloitte's 2026 US health care outlook emphasizes digital delivery as a priority across the industry. For insurance specifically, this means the mobile assessment experience needs to work on the first try, on any phone, in under two minutes. Product managers should be running UX research with actual insurance applicants (not internal stakeholders) to identify friction points. We've written about common UX mistakes in digital health screening that carriers keep making.

Privacy and consent architecture

Biometric data collection triggers state-level privacy regulations (BIPA in Illinois, CCPA in California, and new laws being proposed in multiple states). Product managers need to work with legal and compliance teams now to design consent flows that satisfy current regulations and have room to adapt as new ones pass. This isn't something you can bolt on later.

Current research and evidence

The evidence base for mobile health assessment in insurance is building from multiple directions.

Munich Re's ongoing accelerated underwriting surveys provide the most comprehensive industry data. Their 2024 survey covered carriers representing a significant share of the US life insurance market and found that while adoption of accelerated underwriting is near-universal, the acceleration rates (percentage of apps that go through the fast track) vary enormously between carriers. The gap between top performers and average carriers is widening, and the differentiator is usually data integration, not data access.

RGA's published research on accelerated underwriting emphasizes that digital health data can provide protective value comparable to traditional exams when the data sources are sufficiently recent and comprehensive. Their framework for evaluating new data sources focuses on mortality predictiveness, population coverage, and practical implementation factors.

On the rPPG technology side, the 2025 Frontiers in Digital Health review (Fernández-Ruiz et al.) provides one of the most comprehensive assessments of the field. The review covers heart rate, respiratory rate, blood pressure, and oxygen saturation measurement via camera, with analysis of validation methodologies across dozens of studies. The authors note that while clinical-grade accuracy for all vital signs isn't there yet, several metrics (particularly heart rate and heart rate variability) have reached reliability levels that are useful for screening applications.

McKinsey's health tech analysis for 2026 identifies data platforms and interoperable health records as top enterprise priorities, which aligns with the direction mobile underwriting assessment is heading: more data sources, better integration, automated consumption by underwriting engines.

What 2027 actually looks like

Predictions are usually wrong in the specifics but right in the direction. Here's the direction mobile underwriting health assessment is heading.

By late 2027, the leading carriers will offer a fully mobile underwriting experience where the applicant opens a link on their phone, consents to data pulls, completes a 60-second camera-based health scan, and receives an underwriting decision within minutes. No scheduling, no nurse visits, no lab work for the majority of applicants.

The carriers that get there will have higher conversion rates (fewer applicants dropping off during a slow process), lower per-policy acquisition costs, and faster speed-to-market for new products. The carriers that don't will be competing for the same applicants with a worse experience and higher costs.

Product managers who want their organizations on the right side of that divide need to be building the data pipeline, vendor relationships, and UX infrastructure now. Not in 2027. Now.

Frequently asked questions

What is a mobile underwriting health assessment?

A mobile underwriting health assessment is a health screening process conducted entirely through a smartphone. Instead of scheduling a nurse visit or lab appointment, the insurance applicant completes health questions, authorizes electronic health record and prescription data pulls, and potentially completes a camera-based biometric scan, all from their phone. The collected data feeds directly into the carrier's underwriting engine.

How accurate is phone-based health screening for underwriting?

Accuracy varies by vital sign and technology. Heart rate measurement via rPPG has reached strong correlation with clinical devices in multiple published studies. Blood pressure estimation via camera is less mature but improving. For underwriting purposes, the goal isn't to replace clinical diagnosis but to provide screening-level data that helps stratify risk, similar to how a paramedical exam provides directional health information rather than a clinical workup.

Which carriers are using mobile health assessment in production?

Several large carriers have deployed components of mobile health assessment. John Hancock's collaboration with Munich Re on the alitheia platform is one public example. Many carriers use mobile-first application interfaces combined with electronic health record and prescription data pulls. Full integration of camera-based biometric capture is still in early production and pilot stages at most carriers as of early 2026.

What should product managers prioritize first?

Start with the data pipeline. The biggest risk for 2027 readiness isn't choosing the wrong biometric vendor; it's discovering too late that your underwriting engine can't consume new data types. Build the normalization and integration layer first, then plug in new data sources (including camera-based biometrics) as they mature. Parallel to that, run UX research with real applicants to understand where mobile assessment flows break down.

The mobile underwriting health assessment space is moving toward full biometric capture on any smartphone. Companies building in this space, including Circadify, are working to make camera-based vital sign capture a standard part of the insurance application process. For product managers, the planning window is 2026. The deployment window is 2027. The gap between them is where roadmaps get built or missed.